<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>299(3)</volume><submitter>Billotte M</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To assess factors associated with rapidly progressive interstitial lung disease (ILD) (RP-ILD) at time of ILD diagnosis in a multicentric retrospective cohort study of antisynthetase syndrome (ASyS). We used a complementary unsupervised approach, hierarchical clustering, to delineate distinct phenotypes among ASyS patients with ILD.&lt;h4>Methods&lt;/h4>A total of 132 patients with ASyS, defined according to the 2024 ACR/European Alliance of Associations for Rheumatology (EULAR) ASyS classification criteria, and ILD, diagnosed by CT scan, were included. RP-ILD was defined by the presence of respiratory failure at ILD diagnosis or rapid ILD progression during the first 3 months.&lt;h4>Results&lt;/h4>In our study, 39% of patients had RP-ILD at ILD diagnosis. Multivariate logistic regr</pubmed_abstract><journal>Journal of internal medicine</journal><pagination>365-380</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12869006</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical profiles associated with rapidly progressive interstitial lung disease in antisynthetase syndrome: A multicentric cohort study (TYPASS study).</pubmed_title><pmcid>PMC12869006</pmcid><pubmed_authors>Bonniaud P</pubmed_authors><pubmed_authors>Chaudier A</pubmed_authors><pubmed_authors>Dury S</pubmed_authors><pubmed_authors>Bolko L</pubmed_authors><pubmed_authors>Billotte M</pubmed_authors><pubmed_authors>Bonnotte B</pubmed_authors><pubmed_authors>Campagne J</pubmed_authors><pubmed_authors>Jaussaud R</pubmed_authors><pubmed_authors>Decker P</pubmed_authors><pubmed_authors>Beltramo G</pubmed_authors><pubmed_authors>Valentin S</pubmed_authors><pubmed_authors>Didier K</pubmed_authors><pubmed_authors>Moulinet T</pubmed_authors><pubmed_authors>Magy-Bertrand N</pubmed_authors><pubmed_authors>Meyer A</pubmed_authors><pubmed_authors>Camara H</pubmed_authors><pubmed_authors>Devilliers H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical profiles associated with rapidly progressive interstitial lung disease in antisynthetase syndrome: A multicentric cohort study (TYPASS study).</name><description>&lt;h4>Objectives&lt;/h4>To assess factors associated with rapidly progressive interstitial lung disease (ILD) (RP-ILD) at time of ILD diagnosis in a multicentric retrospective cohort study of antisynthetase syndrome (ASyS). We used a complementary unsupervised approach, hierarchical clustering, to delineate distinct phenotypes among ASyS patients with ILD.&lt;h4>Methods&lt;/h4>A total of 132 patients with ASyS, defined according to the 2024 ACR/European Alliance of Associations for Rheumatology (EULAR) ASyS classification criteria, and ILD, diagnosed by CT scan, were included. RP-ILD was defined by the presence of respiratory failure at ILD diagnosis or rapid ILD progression during the first 3 months.&lt;h4>Results&lt;/h4>In our study, 39% of patients had RP-ILD at ILD diagnosis. Multivariate logistic regr</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Mar</publication><modification>2026-07-15T13:30:35.346Z</modification><creation>2026-07-05T03:08:21.062Z</creation></dates><accession>S-EPMC12869006</accession><cross_references><pubmed>41376133</pubmed><doi>10.1111/joim.70058</doi></cross_references></HashMap>